Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...

Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

The drug maker on Tuesday announced a new 470,000-square-foot facility in Wilmington, Delaware, where it will make Keytruda, the company's immunotherapy treatment for different cancers. The plant ...

The backup bidder to Regeneron is a nonprofit apparently started by former 23andMe CEO Anne Wojcicki. Meet the company that ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 ...

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...

The global cholesterol API market is witnessing robust growth, driven by the expanding application of cholesterol-based raw materials across pharmaceuticals, biotechnology, cosmetics, and advanced ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

AmplifyBio said in a statement April 4, saying the decision to close followed months of efforts to keep the four-year-old ...

Merck is investing $1 billion to build a U.S. plant in Delaware ... ingredients used in the making of such medicines. The drug maker on Tuesday announced a new 470,000-square-foot facility ...

The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing ...